With a keen interest in geriatric medicine, research and education, I am currently undertaking my Doctor of Philosophy at The University of Sydney under main supervisor Professor Sarah Hilmer. My research centres round co-designing digital solutions for older people, that optimises medication management and promotes collaboration with health care practitioners.

Justin is a PhD student at the University of Sydney, currently developing a gabapentinoid deprescribing guideline endorsed by the National Health and Medical Research Council (NHMRC). He brings practical experience from working in community pharmacy, which informs his research focus on safe and evidence-based medication management.

Zena is a final year student completing the Bachelor of Pharmacy with Honours at The University of Sydney. Her research focuses on improving medication-safety in people living with dementia and the co-design of resources and tools in medication management.

My name is Carla Haddad and I am a final year Pharmacy and Management student at the University of Sydney. I am currently undertaking Honours under the supervision of Dr Aili Langford and A/Professor Carl Schneider. My research is focused on deprescribing and how clinicians can approach these conversations with their patients more effectively.

Aisling is a PhD candidate from the Centre for Medicine Use and Safety at Monash University. Her research focuses on deprescribing benzodiazepine receptor agonists in people living with dementia. She is excited to find non-pharmacological approaches to assist with sleep as a replacement for benzodiazepines and z-drugs. Before starting as a PhD student, Aisling completed her BPharm and MPharm with Monash University. Aisling continues to work as a clinical pharmacist at The Alfred Hospital while completing her PhD.

Toni is a PhD student from the School of Pharmacy at the University of Sydney. Her research is on understanding the pharmacodynamic, pharmacokinetic, and pharmacogenomic properties of commonly prescribed fertility mediations to inform optimal use of medications in practice.

With an interest in research ,Amarrah Muker is a final-year Bachelor of Pharmacy (Honours) student at the University of Sydney under main supervisor Doctor Lisa Kouladjian O'donnell. Her Honours research examines tools to measure and simplify medication regimen complexity in older adults, aiming to support medication management.

Paul Chin is a Senior Lecturer at the University of Otago, Christchurch and Senior Medical Officer at Te Whatu Ora Health New Zealand – Waitaha Canterbury. Research interests include therapeutic drug monitoring (including anticoagulants and antimicrobials), quality use of medicines, electronic prescribing, and clinical decision support.

Dr Shin Liau is a pharmacist and Research Fellow at the Centre for Medicine Use and Safety, Monash University. She leads work on optimising medication management for older adults living with frailty and dementia in community and residential aged care settings across Australia, Asia and Europe. With a strong commitment to improving medication safety and effectiveness, her current research addresses the unique challenges of appropriate prescribing by incorporating deprescribing recommendations into clinical practice guidelines.

Stefan Musolino is a biomedical research scientist at The University of Adelaide specializing in neuro-immunopharmacology, chronic and neuropathic pain mechanisms, and behavioural models of pain. His work investigates neuroimmune interactions underlying pain and their implications for therapeutic development. Stefan also has expertise in clinical pharmacogenomics and pharmacokinetic studies, exploring drug interactions and mechanisms of action to improve personalized medicine strategies. He has contributed to multidisciplinary projects advancing the understanding of pain pathways and translating findings into clinical applications.

Dr Mirjana Radovanovic is a Research Scientist in the Clinical Pharmacology Laboratory at the University of Newcastle. She has extensive experience and expertise in therapeutic drug monitoring as performed in pathology services for routine use and in academic research. This unique blend of expertise has enabled her to contribute to projects that span from laboratory to clinical applications, supporting dose optimisation and improving patient outcomes. Her research interests lie entirely within the field of clinical pharmacology with a particular focus on anti-cancer, anti-infective and immunosuppressive drugs. In her current role, she is involved in developing and validating analytical methods and extraction techniques for measurement of therapeutic drug concentrations using liquid chromatography tandem mass spectrometry (LC-MS/MS). Her work has been substantially focused on investigating less invasive techniques, including the use of microsampling devices and fingerprick blood collection, to support personalised and accessible drug monitoring and therapy optimisation.

Dr Michelle Tan is a Research Fellow (National Dementia Clinical Practice Guidelines Development) at the Centre for Medicine Use and Safety (CMUS), Monash University (Parkville Campus), working in close collaboration with the National Centre for Healthy Ageing (NCHA), Cochrane Australia, and the Australian Department of Health and Aged Care on the development of National Clinical Practice Guidelines for Dementia 2026. She also holds ongoing honorary positions as an Affiliate Research Fellow (Global Health) at the Department of Health Service and Population Research, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, UK, and as an Adjunct Research Fellow (Health Services) at The Prince Charles Hospital-Northside Clinical Unit, Greater Brisbane Clinical School, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland (UQ). She has a strong interest and expertise in applying rigorous evidence synthesis methods and leveraging large-scale longitudinal clinical datasets to inform health policies nationally and globally.

Magda is a fourth-year pharmacy student at The University of Queensland, completing her major research project with the Calcium Signalling in Therapeutics Team (CaSTT), under the supervision of Professor Gregory R. Monteith, Dr Melanie Robitaille, Dr Farzaneh Forouz and Professor Sarah Roberts-Thomson. Her work explores how pharmacological modulators of ORAI1 can influence gene expression in prostate cancer cells grown in 3D culture.

Olivia Clink is an Honours student, in her final year of a Bachelor of Advanced Science at UNSW. She majored in both pharmacology and psychology, where she developed a particular interest in molecular pharmacology and G protein-coupled receptors (GPCRs). Olivia is currently completing her honours project under the supervision of Dr. Nicola J. Smith in the Orphan Receptor Laboratory at UNSW, where her project focuses on the biased signalling potential of orphan GPCR, bombesin 3.

I am a pharmacist and a dedicated biomedical scientist and educator. I hold a Master of Medical Science (Pharmacology) and currently pursuing a PhD in Biomedical Sciences at Auckland University of Technology, New Zealand. I am currently exploring absorption, disposition, and cytotoxicity response of antibiotic conjugates of vitamin B₁₂. With a strong background in pharmacology and hands-on experience in teaching and research, I am passionate about student-focused learning and contributing to impactful health science research in a culturally responsive and inclusive environment.

B.S. in Pharmaceutical and Biomedical Engineering, Dong-A University M.S. Candidate in Bio-Medical Sciences, Gachon University

Yining (Courtney) Luo is a PhD candidate in the Molecular Drug Development Group at the Sydney Pharmacy School, The University of Sydney. Her research focuses on antibiotic pharmacology, investigating the structure-function interactions of the human oligopeptide transporter 2 (hPepT2) and its role in the nephrotoxicity of last-line antibiotics used to treat multidrug-resistant Gram-negative infections. Courtney completed her Bachelor of Pharmacy and has a strong interest in antimicrobial resistance and drug discovery.

Fourth year Bachelor of Pharmacy student at Sydney University. Academic awards include Year 12 HSC Dux at Champagnat Catholic College, the 2024 University of Sydney Academic Merit Award, and current enrollment in honours. Clinical pharmacy experience includes currently employment as a pre-intern (student) pharmacist at a hybrid community and clinical hospital role.

Darshna is a clinical pharmacist and final year PhD candidate at the Centre for Medicine Use and Safety at Monash University, Faculty of Pharmacy and Pharmaceutical Sciences. Her PhD explores optimising appropriate medication use in type 2 diabetes for older adults, focused on those living with dementia, frailty or receiving end of life care. Her work includes pharmacoepidemiology studies using linked hospital and administrative data to observe diabetes medication use populations often excluded from clinical trials.

Dr. Mitchel Hurlbert is a Canadian/Australian physician and first year Clinical Pharmacology advanced trainee at St Vincent’s Hospital, Sydney. He obtained his MD at the University of Sydney after completing a Bachelor of Science with Honours in evolutionary biology at Queen’s University in Kingston, Ontario, Canada. He previously contributed to multiple sclerosis research in a basic science laboratory in Calgary, Alberta, Canada. His academic interests include biologic therapies, small molecule inhibitors, and drug development for systemic inflammatory conditions, with a strong focus on reducing health inequalities in access to medicines and clinical trials. Dr. Hurlbert’s long-term goal is dual training in Clinical Pharmacology and Rheumatology, integrating the foundations of clinical pharmacology into his future rheumatology practice to advance safe and cost-effective treatment strategies.

Juhee Koo is a final-year Bachelor of Pharmacy student at the University of Sydney and is completing her Honours research at the Kolling Institute. Her research focuses on pharmacoepidemiology and oncology, using real-world data to investigate medicine safety and effectiveness in clinical practice.

Edward is a community pharmacist in Australia and PhD student at the University of Sydney with a research interest in pharmacoepidemiology in older people, especially people living with dementia in community settings in Australia. He is particularly interested in the prevalence, risk factors and outcomes of high-risk prescribing in this population. His research is aimed at improving the safety and effectiveness of medication use in people living with dementia.

Trong Hieu (Harry) Le is a recent Master of Philosophy graduate from the School of Pharmacy, The University of Sydney. His research focuses on pharmacoepidemiology, dementia, and the quality use of medicines. Harry has experience working with a range of large-scale datasets, including the Person Level Integrated Data Asset (PLIDA), The National Health Data Hub (NHDH), and individual participant data from clinical trials. His research applies advanced pharmacoepidemiological methods and machine learning approach to evaluate medicine use, safety, and treatment outcomes in older adults and people living with dementia."

Yannee Liu is a PhD student from the Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University in Melbourne. Yannee is a clinical pharmacist. Yannee's research areas of interest include potentially inappropriate medication use, health economics and sustainability.

Teoni Antonopoulos is a fourth-year Bachelor of Pharmacy (Honours) student at the University of Sydney. She is currently undertaking her honours research which focuses on the influence of pharmacogenomics on antiplatelet therapy, in particular its impact on patient outcomes. This research contributes to the movement towards precision medicine by highlighting how genetic variation can guide safer and more effective treatments.

Josephine Hughes is an Honours student at The University of Sydney, within the School of Medical Sciences. Her research focuses on determining the value of CYP2C19-informed antiplatelet prescribing, to advance personalised approaches to cardiovascular treatment within Australia. Josephine is completing her Honours thesis under the supervision of A/Prof Sophie Stocker and is excited to present her work at the 2025 ASCEPT conference and have the opportunity to connect with peers and experts in clinical pharmacology.

Mihin Meegasdeniya is a medical student at UNSW with research interests in psychiatry, pharmacogenomics, and primary care. He has clinical and academic experience in mental health, with a focus on personalised approaches to improving treatment outcomes in mental health disorders.